Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

EYPT.US Logo

EYPT.US - Current Price

$15.94

Company Information

▼
Company Name
Eyepoint Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US30233G2093
CIK: 0001314102
CUSIP: 74439M107
Currency: USD
Full Time Employees: 165
Phone: 617 926 5000
Website: https://eyepoint.bio
Fiscal Year End: December
IPO Date: Jan 27, 2005
Description:

EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as EyePoint Pharmaceuticals, Inc. and changed its name to EyePoint, Inc. in December 2025. EyePoint, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Address:

480 Pleasant Street, Watertown, MA, United States, 02472

Directors & Officers

▼
Name Title Year Born
Dr. Jay S. Duker M.D. President, CEO & Director 1959
Mr. George O. Elston CPA Executive VP & CFO 1965
Dr. Ramiro Ribeiro M.D., Ph.D. Chief Medical Officer 1983
Dr. Marcia Sellos-Moura Ph.D. Chief Scientific Officer NA
Mr. Ron I. Honig Esq. Chief Legal Officer & Company Secretary NA
Ms. Jennifer Leonard Chief People Officer & Senior VP of IT NA
Mr. David Scott Jones M.A. Senior VP & Chief Commercial Officer 1967
Ms. Isabelle Lefebvre Chief Regulatory Officer NA
Mr. Michael J. Maciocio Chief Manufacturing Officer NA
Dr. Anna Kluczewska CEO of AION Diagnostics Ltd, President of AION Diagnostics Ltd and Director of AION Diagnostics Ltd NA

Shares Statistics

▼
Shares Outstanding: 82.79M
Shares Float: 61.87M
% Insiders: 275.50%
% Institutions: 8,741.90%
Short % Float: 10.24%

Valuation Metrics

▼
Enterprise Value: $1.16B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $1.32B
EBITDA: $-216.25M
Book Value: $2.88
Earnings/Share: $-3.00
Profit Margin: 0.00%
Operating Margin: -6,420.81%
ROA (TTM): -49.39%
ROE (TTM): -98.23%
Revenue (TTM): $42.34M
Revenue/Share (TTM): $0.62
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -90.80%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.75 N/A 10,000.00%
Sep 30, 2025 -0.85 -0.77 N/A -1,038.96%
Jun 30, 2025 -0.85 -0.81 N/A -493.83%
Mar 31, 2025 -0.65 -0.41 N/A -5,853.66%
Dec 31, 2024 -0.64 -0.48 N/A -3,431.27%
Sep 30, 2024 -0.54 -0.55 N/A 181.82%
Jun 30, 2024 -0.58 -0.52 N/A -1,153.85%
Mar 31, 2024 -0.55 -0.42 N/A -3,095.24%
Dec 31, 2023 -0.33 -0.49 N/A 3,265.31%
Sep 30, 2023 -0.33 -0.51 N/A 3,529.41%
Jun 30, 2023 -0.61 0.60 N/A -20,166.67%
Mar 31, 2023 -0.56 -0.68 N/A 1,764.71%
Dec 31, 2022 -1.16 -0.61 N/A -9,016.39%
Sep 30, 2022 -0.49 -0.70 N/A 3,000.00%
Jun 30, 2022 -0.52 -0.52 N/A 0.00%
Mar 31, 2022 -0.56 -0.58 N/A 344.83%
Dec 31, 2021 -0.59 -0.53 N/A -1,132.08%
Sep 30, 2021 -0.58 -0.40 N/A -4,500.00%
Jun 30, 2021 -0.35 -0.43 N/A 1,860.47%
Mar 31, 2021 -0.50 -0.46 N/A -869.57%
Dec 31, 2020 -1.00 -0.17 N/A -48,823.53%
Sep 30, 2020 -0.30 -0.30 N/A 0.00%
Jun 30, 2020 -1.00 -1.05 N/A 476.19%
Mar 31, 2020 -1.10 -0.95 N/A -1,578.95%
Dec 31, 2019 -1.00 -1.16 N/A 1,379.31%
Sep 30, 2019 -1.50 -1.37 N/A -948.91%
Jun 30, 2019 -1.10 -1.20 N/A 833.33%
Mar 31, 2019 -1.60 -1.37 N/A -1,678.83%
Dec 31, 2018 -1.20 -1.40 N/A 1,428.57%
Sep 30, 2018 -1.90 -1.47 N/A -2,925.17%
Jun 30, 2018 -1.90 -1.07 N/A -7,757.01%
Mar 31, 2018 -1.10 -1.30 N/A 1,538.46%
Dec 31, 2017 -0.13 -0.15 N/A 1,333.33%
Sep 30, 2017 -1.50 -1.50 N/A 0.00%
Jun 30, 2017 -1.60 -1.50 N/A -666.67%
Mar 31, 2017 -1.50 -1.50 N/A 0.00%
Dec 31, 2016 0.00 -1.83 N/A 9,989.07%
Sep 30, 2016 -2.10 -1.90 N/A -1,052.63%
Jun 30, 2016 -1.90 -1.25 N/A -5,200.00%
Mar 31, 2016 -1.50 -1.95 N/A 2,307.69%
Dec 31, 2015 -1.80 -1.50 N/A -2,000.00%
Sep 30, 2015 -1.70 -1.45 N/A -1,724.14%
Jun 30, 2015 -1.70 -1.35 N/A -2,592.59%
Mar 31, 2015 -1.70 -1.27 N/A -3,385.83%
Dec 31, 2014 -1.40 -1.30 N/A -769.23%
Sep 30, 2014 6.70 -1.20 N/A 65,833.33%
Jun 30, 2014 -1.40 -1.45 N/A 344.83%
Mar 31, 2014 -0.80 -1.50 N/A 4,666.67%
Dec 31, 2013 -1.30 -1.30 N/A 0.00%
Sep 30, 2013 -1.40 -1.30 N/A -769.23%
Jun 30, 2013 -1.70 -1.20 N/A -4,166.67%
Mar 31, 2013 -1.20 -1.30 N/A 769.23%
Dec 31, 2012 -1.10 -1.30 N/A 1,538.46%
Sep 30, 2012 -1.10 -1.00 N/A -1,000.00%
Jun 30, 2012 -1.10 -1.90 N/A 4,210.53%
Mar 31, 2012 -1.30 -1.75 N/A 2,571.43%
Dec 31, 2011 -1.30 -1.75 N/A 2,571.43%
Sep 30, 2011 -1.20 -2.10 N/A 4,285.71%
Jun 30, 2011 -0.10 -1.80 N/A 9,444.44%
Mar 31, 2011 -1.30 -2.15 N/A 3,953.49%
Dec 31, 2010 -1.50 4.50 N/A -13,333.33%
Sep 30, 2010 -1.70 -1.45 N/A -1,724.14%
Jun 30, 2010 6.80 N/A N/A N/A
Mar 31, 2010 -0.15 -1.90 N/A 9,229.47%
Dec 31, 2009 -0.01 N/A N/A N/A
Sep 30, 2009 -0.87 N/A N/A N/A
Jun 30, 2009 -0.29 N/A N/A N/A
Mar 31, 2009 -0.35 N/A N/A N/A
Dec 31, 2008 -0.48 N/A N/A N/A
Sep 30, 2008 -0.26 N/A N/A N/A
Jun 30, 2008 -35.00 N/A N/A N/A
Mar 31, 2008 -12.05 N/A N/A N/A
Dec 31, 2007 -12.70 N/A N/A N/A
Sep 30, 2007 -1.78 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $99.70M $N/A $418.47M $81.96M $336.50M
2023-12-31 $281.26M $N/A $355.18M $88.86M $266.32M
2022-12-31 $95.63M $N/A $180.36M $83.99M $96.37M
2021-12-31 $178.59M $N/A $263.37M $78.99M $184.38M
2020-12-31 $44.91M $N/A $91.72M $73.18M $18.54M
2019-12-31 $22.21M $N/A $72.97M $64.64M $8.33M
2018-12-31 $38.78M $N/A $71.67M $59.98M $11.69M
2017-12-31 $16.90M $N/A $18.68M $5.34M $13.34M
2016-12-31 $15.31M $N/A $31.62M $10.74M $20.88M
2015-12-31 $19.12M $N/A $32.37M $9.00M $23.37M
2014-12-31 $15.33M $N/A $22.67M $7.75M $14.92M
2013-12-31 $6.90M $N/A $16.25M $8.55M $7.70M
2012-12-31 $4.63M $N/A $20.60M $6.96M $13.64M
2011-12-31 $12.91M $N/A $47.11M $9.68M $37.43M
2010-12-31 $15.51M $N/A $43.01M $9.97M $33.04M
2009-12-31 $6.90M $N/A $37.10M $13.56M $23.54M
2008-12-31 $9.85M $N/A $39.23M $17.44M $21.79M
2007-12-31 $2.67M $N/A $86.12M $20.21M $65.91M
2006-12-31 $4.25M $N/A $97.60M $31.40M $66.20M
2005-12-31 $9.79M $N/A $62.30M $1.56M $60.74M
2004-12-31 $9.79M $N/A $62.30M $1.56M $60.74M
2003-12-31 $21.79M $N/A $28.05M $1.35M $25.60M
2002-12-31 $792.81K $N/A $4.82M $588.38K $4.09M
2001-12-31 $N/A $N/A $N/A $N/A $N/A
2000-12-31 $1.64M $N/A $4.72M $145.74K $4.57M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 20, 2024 N/A N/A N/A N/A N/A N/A
Jul 12, 2024 N/A N/A N/A N/A N/A N/A
May 14, 2024 N/A N/A N/A N/A N/A N/A
May 06, 2024 N/A N/A N/A N/A N/A N/A
Apr 18, 2024 N/A N/A N/A N/A N/A N/A
Feb 02, 2024 N/A N/A N/A N/A N/A N/A
Jan 26, 2024 N/A N/A N/A N/A N/A N/A
Jan 25, 2024 N/A N/A N/A N/A N/A N/A
Jan 23, 2024 N/A N/A N/A N/A N/A N/A
Jan 23, 2024 N/A N/A N/A N/A N/A N/A
Jan 11, 2024 N/A N/A N/A N/A N/A N/A
Jan 11, 2024 N/A N/A N/A N/A N/A N/A
Jan 09, 2024 N/A N/A N/A N/A N/A N/A
Jan 08, 2024 N/A N/A N/A N/A N/A N/A
Dec 13, 2023 N/A N/A N/A N/A N/A N/A
Dec 08, 2023 N/A N/A N/A N/A N/A N/A
Dec 06, 2023 N/A N/A N/A N/A N/A N/A
Dec 04, 2023 N/A N/A N/A N/A N/A N/A
Dec 04, 2023 N/A N/A N/A N/A N/A N/A
Sep 01, 2023 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist